Protection against neonatal diarrhea you can count on.
Vaccinate sows with LitterGuard® or LitterGuard® LT-C to help protect your piglets from scours.
Count on healthy pigs
LitterGuard and LitterGuard LT-C vaccines help protect pigs against neonatal diarrhea, which can impact overall health, decrease productivity and increase piglet mortality.
Both LitterGuard and LitterGuard LT-C contain a sterile adjuvant to enhance the immune response by using the animal’s natural defense system to fight disease.
Count on performance
LitterGuard and LitterGuard LT-C vaccines are approved for use in healthy pregnant sows and gilts for passive transfer of protective maternal antibodies to their piglets to protect against neonatal diarrhea.
LitterGuard helps protect against illness caused by enterotoxigenic strains of Escherichia coli (E. coli) having the K99, K88, 987P or F41 adherence factors.
LitterGuard LT-C also helps protect against neonatal diarrhea caused by beta toxin produced by Clostridium perfringens Type C.
Count on comprehensive support
You can count on the renowned technical support and customer service from Zoetis.
General directions: Shake well. Aseptically administer 2 mL intramuscularly or subcutaneously.
Primary vaccination: Healthy pregnant swine should receive two doses administered three weeks apart during the last half of pregnancy. The second dose should be given at least two weeks before farrowing.
Revaccination: Pregnant swine should be revaccinated with a single dose at least two weeks before each subsequent farrowing.
Good animal husbandry and herd health management practices should be employed.
Store at 2° to 7° C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze.
Use entire contents when first opened.
Sterilized syringes and needles should be used to administer this vaccine.
Do not vaccinate within 21 days before slaughter.
As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.